GSK

BLENREP

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / BLENREP – J9037

Manufacturer:

GSK

Name:

BLENREP

HCPCS Code Descriptor:

Injection, belantamab mafodotin-blmf, 0.5 mg

Category:

J Code

HCPCS:

J9037

NDC(s):

00173-0896-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

BLENREP is an Oncology drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J9037 is aligned to the drug BLENREP.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/21

HCPCS Effective Date:

4/1/21

HCPCS Short Description:

Inj belantamab mafodot blmf

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found